Taking Stock of Surgeons’ Integrity and Vitality: Why the “Three A’s” No Longer Tell the Whole Story Lauren Kosinski Healthcare Policy and Outcomes Open access 28 October 2009 Pages: 351 - 353
K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy Kiran TuragaDavid Shibata Colorectal Cancer Open access 20 November 2009 Pages: 354 - 355
Mini-Mesohepatectomy for Colorectal Metastasis Invading the Middle Hepatic Vein at the Hepatocaval Confluence: Educational Video Demonstrating IOUS Use in Modern Hepatic Surgery Masatoshi MakuuchiHideki Abe Hepatobiliary Tumors Open access 01 December 2009 Pages: 356 - 357
Why Does No One Want to Perform Lymph Node Dissection Anymore? Kelly M. McMasters Melanomas Open access 26 November 2009 Pages: 358 - 361
Renal Cell Carcinoma and Prognostic Factors Predictive of Survival M. SorbelliniG. Bratslavsky Urologic Oncology Open access 12 November 2009 Pages: 362 - 363
A Fire in Our Hearts: Passion and the Art of Surgery S. Eva Singletary Healthcare Policy and Outcomes 03 December 2009 Pages: 364 - 370
Impact of Selection Bias on the Utilization of Adjuvant Therapy for Pancreas Adenocarcinoma Andrew J. RussSharon M. WeberClifford S. Cho Healthcare Policy and Outcomes 23 October 2009 Pages: 371 - 376
National Quality Measures for Breast Centers (NQMBC): A Robust Quality Tool C. S. KaufmanL. ShockneyQuality Initiative Committee Breast Oncology 16 October 2009 Pages: 377 - 385
Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension Ozgur MeteLorne RotsteinSylvia L. Asa Endocrine Tumors 01 December 2009 Pages: 386 - 391
The Utility of Metaiodobenzylguanidine Single Photon Emission Computed Tomography/Computed Tomography (MIBG SPECT/CT) for the Diagnosis of Pheochromocytoma Goswin Y. Meyer-RochowGeoff P. SchembriStan B. Sidhu Endocrine Tumors 01 December 2009 Pages: 392 - 400
Complete Femoral Nerve Resection with Soft Tissue Sarcoma: Functional Outcomes Kevin B. JonesPeter C. FergusonJay S. Wunder Bone and Soft Tissue Sarcomas 20 October 2009 Pages: 401 - 406
Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate Chandrajit P. RautQian WangMonica M. Bertagnolli Bone and Soft Tissue Sarcomas 07 November 2009 Pages: 407 - 415
KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer Garrett M. NashMark GimbelPhilip B. Paty Gastrointestinal Oncology 08 October 2009 Pages: 416 - 424
Stage III Colorectal Cancer: Molecular Disparity Between Primary Cancers and Lymph Node Metastases Craig A. MessickJames M. ChurchMatthew F. Kalady Colorectal Cancer 03 November 2009 Pages: 425 - 431
Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer Renato CostiDavide Di MauroVincenzo Violi Colorectal Cancer 20 November 2009 Pages: 432 - 440
Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer Glenda G. CallenderPrajnan DasBarry W. Feig Gastrointestinal Oncology 22 October 2009 Pages: 441 - 447
Recurrence After Curative Resection of Early Gastric Cancer Ho Geun YounJi Yeong AnSung Kim Gastrointestinal Oncology 11 November 2009 Pages: 448 - 454
Positive Peritoneal Washing Cytology in Multiple Cavities Can Predict Poor Prognosis of Advanced Gastric Cancer Patients Yoichiro HommaShinichiro UshidaKazufumi Suzuki Gastrointestinal Oncology 22 October 2009 Pages: 455 - 460
Malignant Ascites Symptom Cluster in Patients Referred for Paracentesis Amna HusainAndrea BezjakAlexandra Easson Gastrointestinal Oncology 29 October 2009 Pages: 461 - 469
Temporary Placement of Self-Expanding Oesophageal Stents as Bridging for Neo-Adjuvant Therapy Felix B. LangerSebastian F. SchoppmannJohannes Zacherl Gastrointestinal Oncology 27 October 2009 Pages: 470 - 475
Pneumonectomy After Neoadjuvant Chemotherapy and Radiation for Advanced-Stage Lung Cancer Thomas NgAriel E. BirnbaumThomas A. Dipetrillo Thoracic Oncology 14 November 2009 Pages: 476 - 482
Minimesohepatectomy for Colorectal Liver Metastasis Invading the Middle Hepatic Vein at the Hepatocaval Confluence Guido TorzilliFlorin BoteaAngela Palmisano Hepatobiliary Tumors 23 October 2009 Pages: 483 - 483
Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option Akshat SaxenaLourens BesterDavid L. Morris Gastrointestinal Oncology 30 October 2009 Pages: 484 - 491
Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases Terence C. ChuaAkshat SaxenaDavid L. Morris Hepatobiliary Tumors 24 October 2009 Pages: 492 - 501
Preoperative Diabetes Mellitus and Long-Term Survival After Resection of Pancreatic Adenocarcinoma Carrie K. ChuAshley E. MazoDavid A. Kooby Pancreatic Tumors 03 November 2009 Pages: 502 - 513
Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy T. Peter KinghamKatherine S. PanageasDaniel G. Coit Melanomas 19 November 2009 Pages: 514 - 520
Reevaluation of the Locoregional Recurrence Rate in Melanoma Patients With a Positive Sentinel Node Compared to Patients With Palpable Nodal Involvement Hidde J. VeenstraIris M. C. van der PloegOmgo E. Nieweg Melanomas 07 November 2009 Pages: 521 - 526
Evaluation of Clinical and Histomorphological Parameters as Potential Predictors of Occult Metastases in Sentinel Lymph Nodes of Early Squamous Cell Carcinoma of the Oral Cavity Mete GoerkemJulia BraunSandro J. Stoeckli Head and Neck Oncology 16 October 2009 Pages: 527 - 535
Postoperative Morbidity and Mortality of Head and Neck Cancers in Patients With Liver Cirrhosis Undergoing Surgical Resection Followed by Microsurgical Free Tissue Transfer Huang-Kai KaoKai-Ping ChangFu-Chan Wei Reconstructive Oncology 11 November 2009 Pages: 536 - 543
Prognostic Factors Influencing Long-Term Survival of Patients Undergoing Nephron-Sparing Surgery for Nonmetastatic Renal-Cell Carcinoma (RCC) with Imperative Indications Axel HaferkampMartin KuroschMarkus Hohenfellner Urologic Oncology 01 December 2009 Pages: 544 - 551
Erratum to: Axillary Recurrence Rate Following Negative Sentinel Node Biopsy for Invasive Breast Cancer: Long-Term Follow-Up John V. KilukQuan P. LyCharles E. Cox Erratum 03 December 2009 Pages: 552 - 557
What is an Adequate Margin for Breast-Conserving Surgery? Surgeon Attitudes and Correlates Michelle AzuPaul AbrahamseMonica Morrow Breast Oncology 22 October 2009 Pages: 558 - 563
E2F1 Expression Predicts Outcome in Korean Women Who Undergo Surgery for Breast Carcinoma Mi Jung KwonEun Sook NamWon Jae Lee Breast Oncology 20 October 2009 Pages: 564 - 571
KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases Garrett M. NashMark GimbelPhilip B. Paty Translational Research and Biomarkers 01 September 2009 Pages: 572 - 578
Beyond the False Negative Rate: Development of Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer May Lynn QuanBryan J. WellsAnna R. Gagliardi Translational Research and Biomarkers 26 August 2009 Pages: 579 - 591
Inhibition of Autophagy Potentiates Sulforaphane-Induced Apoptosis in Human Colon Cancer Cells Takeshi NishikawaNelson H. TsunoHirokazu Nagawa Translational Research and Biomarkers 15 October 2009 Pages: 592 - 602
Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma Jeng-Fong ChiouCheng-Jeng TaiYu-Jia Chang Translational Research and Biomarkers 15 October 2009 Pages: 603 - 612
Characterizing the HER2/neu Status and Metastatic Potential of Breast Cancer Stem/Progenitor Cells SuEllen J. PommierGlenda G. QuanRodney F. Pommier Translational Research and Biomarkers 17 October 2009 Pages: 613 - 623
Enhancing Detection of Circulating Tumor Cells with Activating KRAS Oncogene in Patients with Colorectal Cancer by Weighted Chemiluminescent Membrane Array Method Ming-Je YangHua-Hsien ChiuShiu-Ru Lin Translational Research and Biomarkers 24 November 2009 Pages: 624 - 633
p53 Genotype Predicts Response to Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus Makoto YamasakiHiroshi MiyataYuichiro Doki Translational Research and Biomarkers 26 November 2009 Pages: 634 - 642
Adenoviral Oncolytic Suicide Gene Therapy for a Peritoneal Dissemination Model of Gastric Cancer in Mice Yu ImamuraShinji IshikawaHideo Baba Translational Research and Biomarkers 10 December 2009 Pages: 643 - 652
Caution in Adding Bevacizumab in the Adjuvant Treatment of Breast Cancer Dimosthenis ZiogasDimitrios Roukos Medical Oncology 04 November 2009 Pages: 653 - 654
Continued Exploration of Bevacizumab in Breast Cancer Rita S. MehtaMin-Ying Su Breast Oncology Open access 21 November 2009 Pages: 655 - 656
A Different Variable to Stratify Risk in Resected Gastric Cancer Esther Uña Cidón Gastrointestinal Oncology 31 October 2009 Pages: 657 - 658
The Lymph Node Ratio Staging System in Gastric Cancer Da-zhi Xu Gastrointestinal Oncology 04 November 2009 Pages: 659 - 659
Potential Cost-Effectiveness of US-Guided FNAC in Melanoma Patients as a Primary Procedure and in Follow-Up Alexander C. J. van AkkooiChristiane A. VoitAlexander M. M. Eggermont Melanomas Open access 17 November 2009 Pages: 660 - 662
In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma Rachael L. MortonKirsten HowardJohn F. Thompson Melanomas 05 December 2009 Pages: 663 - 664
